ID   LS
AC   CVCL_2105
DR   BioSample; SAMN03473430
DR   cancercelllines; CVCL_2105
DR   Cell_Model_Passport; SIDM01794
DR   Cosmic; 2058108
DR   DepMap; ACH-001548
DR   DSMZ; ACC-675
DR   DSMZCellDive; ACC-675
DR   GEO; GSM3145721
DR   Wikidata; Q54903034
RX   PubMed=2026421;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~45 hours (DSMZ=ACC-675).
CC   Omics: Deep exome analysis.
ST   Source(s): DepMap=ACH-001548; DSMZ=ACC-675
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 11,14
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   PubMed=2026421; DOI=10.1007/BF00201542;
RA   Rudolph G., Schilbach-Stuckle K., Handgretinger R., Kaiser P.,
RA   Hameister H.;
RT   "Cytogenetic and molecular characterization of a newly established
RT   neuroblastoma cell line LS.";
RL   Hum. Genet. 86:562-566(1991).
//